Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay-Reference-Cited by-同舟云学术

Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay

Published:2018-10-08 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Jang Cheongyun,Yadav Dharmendra K.^ORCID,Subedi Lalita^ORCID,Venkatesan Ramu,Venkanna Arramshetti,Afzal Sualiha,Lee Eunhee,Yoo Jaewook,Ji Eunhee,Kim Sun Yeou,Kim Mi-hyun^ORCID

Funder

Korea Health Industry Development Institute

National Research Foundation of Korea

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-33354-6.pdf

Reference79 articles.

1. Minati, L., Edginton, T., Bruzzone, M. G. & Giaccone, G. Current concepts in Alzheimer’s disease: a multidisciplinary review. American journal of Alzheimer’s disease and other dementias 24, 95–121, https://doi.org/10.1177/1533317508328602 (2009).

2. Alzheimer’s Association. Alzheimer’s Disease Facts and Figures. Alzheimer’s & Dementia 11, 332 (2015).

3. Babic, T. The cholinergic hypothesis of Alzheimer’s disease: a review of progress. Journal of neurology, neurosurgery and psychiatry 67, 558 (1999).

4. Kryger, G. et al. Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. Acta crystallographica. Section D, Biological crystallography 56, 1385–1394 (2000).

5. Martinez, A. & Castro, A. Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer’s disease. Expert Opin Inv Drug 15, 1–12, https://doi.org/10.1517/13543784.15.1.1 (2006).

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholinesterase Inhibitory Activity and Molecular Docking Studies of Isocryptolepine‐Triazole Adducts;ChemMedChem;2024-09-12

2. Could Mushrooms’ Secondary Metabolites Ameliorate Alzheimer Disease? A Computational Flexible Docking Investigation;Journal of Medicinal Food;2024-08-09

3. Hydroxygenkwanin exerts a neuroprotective effect by activating the Nrf2/ARE signaling pathway;Food and Chemical Toxicology;2024-08

4. Coptisine reverses Alzheimer’s disease by targeting cholinergic and amyloidogenic pathways;Medical Hypotheses;2024-08

5. Synthesis and Structure of Novel Phenothiazine Derivatives, and Compound Prioritization via In Silico Target Search and Screening for Cytotoxic and Cholinesterase Modulatory Activities in Liver Cancer Cells and In Vivo in Zebrafish;ACS Omega;2024-07-03